The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A prospective, open label, multicenter, randomized phase II trial: Sequential therapy with bevacizumab, RAd001 (everolimus) and axitinib in metastatic renal cell carcinoma (mRCC) (BERAT study).
 
Viktor Grünwald
Stock and Other Ownership Interests - AstraZeneca; Bristol-Myers Squibb; MSD
Honoraria - Ars tempi; AstraZeneca; Bayer; Bristol-Myers Squibb; Cerulean Pharma; COCS GmbH; Eisai; EUSA Pharma; Exelixis; Ipsen; Janssen-Cilag; Lilly; MedKom Akademie; Merck Serono; MSD Oncology; NewConceptOncology; Novartis; Pfizer; PharmaMar; Promedior; Roche; Update Oncology
Consulting or Advisory Role - Bristol-Myers Squibb; Cerulean Pharma; ClinSol; Ipsen; Lilly; MSD Oncology; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb; Novartis (Inst)
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; Ipsen; MSD Oncology; Novartis; Pfizer
 
Lothar Bergmann
Research Funding - Renal Cell Carcinoma (Inst)
Travel, Accommodations, Expenses - Roche
 
Peter J. Goebell
Honoraria - Astellas Oncology; AstraZeneca; Bayer Health; Bristol-Myers Squibb; Eisai; Ipsen; Janssen; Novartis; Pfizer; Roche; Sanofi
Consulting or Advisory Role - Astellas Oncology; AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; Ipsen; Janssen; Novartis; Pfizer; Roche; Sanofi
 
Arne Strauss
Honoraria - Amgen; Bayer; Bristol-Myers Squibb; Ipsen; MSD Oncology; Novartis; Pfizer; Roche
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Eisai; Roche
Travel, Accommodations, Expenses - Ipsen
 
Johannes Meiler
Honoraria - Amgen; Lilly; Novartis; Pfizer; Roche
 
Arndt Hartmann
No Relationships to Disclose
 
Jens Bedke
Consulting or Advisory Role - Astellas Oncology; AstraZeneca; Bristol-Myers Squibb; Eisai; EUSA Pharma; Ipsen; MSD; Nektar; Novartis; Pfizer; Roche
Speakers' Bureau - Bristol-Myers Squibb; Eisai; EUSA Pharma; Ipsen; MSD; Novartis; Pfizer; Roche
Research Funding - Bristol-Myers Squibb; Eisai; Ipsen; MSD; Novartis; Pfizer; Roche